Taficita

✅ HIV treatment
✅ Reduces viral load
✅ Boosts immune system
✅ Lowers transmission risk
✅ Improves life expectancy

Taficita contains Emtricitabine and Tenofovir.

Product Overview

Taficita is a medication containing the active ingredients Emtricitabine (200mg) and Tenofovir disoproxil fumarate (25mg) in the form of tablets. It is a combination antiretroviral therapy (ART) used in the treatment of HIV-1 infection in adults and pediatric patients weighing at least 17kg. Taficita belongs to a class of drugs known as nucleoside reverse transcriptase inhibitors (NRTIs), which work by inhibiting the replication of the HIV virus, thus reducing the viral load in the body.

Uses

Taficita is indicated for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 17kg. It is used in combination with other antiretroviral agents as part of a comprehensive regimen for the management of HIV-1 infection. By suppressing viral replication, Taficita helps control the progression of HIV disease and reduces the risk of developing opportunistic infections or other complications associated with HIV infection.

How to Use

Take Taficita tablets orally once daily with or without food, as directed by your doctor. Swallow the tablet whole with a full glass of water. Do not crush, chew, or break the tablet before swallowing. It is important to take Taficita consistently at the same time each day to maintain effective drug levels in your body and maximize treatment outcomes.

How it Works

Taficita contains two active ingredients, Emtricitabine and Tenofovir disoproxil fumarate, which work synergistically to inhibit the activity of the HIV-1 reverse transcriptase enzyme. This enzyme is essential for the replication of the HIV virus, allowing it to convert viral RNA into DNA, which can then be integrated into the host cell’s genome. By blocking this process, Taficita helps prevent the formation of new viral particles, thereby reducing the viral load and slowing the progression of HIV disease.

Dosage and Administration

The recommended dosage of Taficita for adults and pediatric patients weighing at least 17kg is one tablet taken orally once daily with or without food. Dosage adjustments may be necessary in patients with renal impairment or those receiving concomitant nephrotoxic agents. It is important to follow your doctor’s instructions regarding dosage and administration to ensure optimal treatment outcomes.

Benefits

  • Effectively treats HIV-1 infection in adults and pediatric patients
  • Helps suppress viral replication and reduce viral load
  • Supports immune system function and prevents opportunistic infections
  • Convenient once-daily dosing regimen
  • Well-tolerated with a favorable safety profile

Common Side Effects

Common side effects of Taficita may include nausea, diarrhea, headache, fatigue, and abdominal pain. These side effects are usually mild to moderate in severity and tend to improve over time as your body adjusts to the medication. However, if any side effects persist or worsen, notify your doctor promptly.

Common Concerns

Common concerns associated with Taficita include the potential for drug interactions with other medications, particularly those that affect renal function or are metabolized by the kidneys. It is important to inform your doctor about all medications, supplements, and herbal products you are taking before starting Taficita.

Warnings

Taficita may cause or exacerbate renal impairment, particularly in patients with pre-existing renal disease or those receiving concomitant nephrotoxic agents. Close monitoring of renal function is recommended, and dosage adjustments may be necessary in patients with impaired renal function. Additionally, Taficita is not recommended for use in patients with severe hepatic impairment.

Storage Information

Store Taficita tablets at room temperature away from moisture and heat. Keep the medication out of reach of children and pets. Do not store Taficita in the bathroom or near the kitchen sink, where it may be exposed to moisture. Discard any unused or expired tablets properly, following local regulations.

Disclaimer:

Our sole intention is to ensure that its consumers get information that is expert-reviewed, accurate, and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover all possible side effects, drug interactions, or warnings or alerts. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

Strength

200/25 mg

Quantity

1 Bottle/s, 2 Bottle/s, 3 Bottle/s, 6 Bottle/s